JCL Roundtable: Dietary recommendations and intermittent fasting and time-restricted eating

IF 4.6 3区医学 Q2 PHARMACOLOGY & PHARMACY Journal of clinical lipidology Pub Date : 2025-07-01 DOI:10.1016/j.jacl.2025.02.018

Kevin C. Maki PhD, CLS, MNLA, FTOS, FAHA , Carol F. Kirkpatrick PhD, MPH, RDN, CLS, FNLA , Michael J. Wilkinson MD, FACC, FNLA , Kristina S. Petersen PhD, APD, FAHA

{"title":"JCL Roundtable: Dietary recommendations and intermittent fasting and time-restricted eating","authors":"Kevin C. Maki PhD, CLS, MNLA, FTOS, FAHA , Carol F. Kirkpatrick PhD, MPH, RDN, CLS, FNLA , Michael J. Wilkinson MD, FACC, FNLA , Kristina S. Petersen PhD, APD, FAHA","doi":"10.1016/j.jacl.2025.02.018","DOIUrl":null,"url":null,"abstract":"<div><div><span><span>Lifestyle intervention is the cornerstone of the prevention of atherosclerotic cardiovascular disease (ASCVD). Several health authorities and scientific organizations have provided dietary guidance for </span>ASCVD prevention<span><span>, including recommendations for healthful dietary patterns. Recently, intermittent fasting and time-restricted eating (TRE) have become popular dietary approaches. Findings from clinical studies suggest that intermittent fasting and TRE may result in improvements in cardiometabolic </span>risk factors, especially in patients with metabolic dysfunction. This </span></span><em>Journal of Clinical Lipidology</em> Roundtable presents a conversation between Drs. Carol F. Kirkpatrick, Kevin C. Maki, Kristina S. Petersen, and Michael J. Wilkinson about dietary recommendations, intermittent fasting, and TRE. The discussion highlights the current dietary recommendations for ASCVD prevention and the potential roles of intermittent fasting and TRE for improving cardiometabolic health.</div></div>","PeriodicalId":15392,"journal":{"name":"Journal of clinical lipidology","volume":"19 4","pages":"Pages 748-758"},"PeriodicalIF":4.6000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of clinical lipidology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1933287425000522","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}

引用次数: 0

Abstract

Lifestyle intervention is the cornerstone of the prevention of atherosclerotic cardiovascular disease (ASCVD). Several health authorities and scientific organizations have provided dietary guidance for ASCVD prevention, including recommendations for healthful dietary patterns. Recently, intermittent fasting and time-restricted eating (TRE) have become popular dietary approaches. Findings from clinical studies suggest that intermittent fasting and TRE may result in improvements in cardiometabolic risk factors, especially in patients with metabolic dysfunction. This Journal of Clinical Lipidology Roundtable presents a conversation between Drs. Carol F. Kirkpatrick, Kevin C. Maki, Kristina S. Petersen, and Michael J. Wilkinson about dietary recommendations, intermittent fasting, and TRE. The discussion highlights the current dietary recommendations for ASCVD prevention and the potential roles of intermittent fasting and TRE for improving cardiometabolic health.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

JCL 圆桌会议：膳食建议与间歇性禁食和限时进食。

生活方式干预是预防动脉粥样硬化性心血管疾病（ASCVD）的基石。一些卫生当局和科学组织为预防ASCVD提供了饮食指导，包括健康饮食模式的建议。最近，间歇性禁食和限时饮食（TRE）已成为流行的饮食方法。临床研究结果表明，间歇性禁食和TRE可能导致心脏代谢危险因素的改善，特别是在代谢功能障碍患者中。本临床脂质学圆桌会议杂志介绍了博士之间的对话。Carol F. Kirkpatrick, Kevin C. Maki, Kristina S. Petersen和Michael J. Wilkinson关于饮食建议，间歇性禁食和TRE。讨论强调了目前预防ASCVD的饮食建议，以及间歇性禁食和TRE在改善心脏代谢健康方面的潜在作用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Journal of clinical lipidology 医学-药学

CiteScore

7.00

自引率

6.80%

发文量

209

审稿时长

49 days

期刊介绍： Because the scope of clinical lipidology is broad, the topics addressed by the Journal are equally diverse. Typical articles explore lipidology as it is practiced in the treatment setting, recent developments in pharmacological research, reports of treatment and trials, case studies, the impact of lifestyle modification, and similar academic material of interest to the practitioner. Sections of Journal of clinical lipidology will address pioneering studies and the clinicians who conduct them, case studies, ethical standards and conduct, professional guidance such as ATP and NCEP, editorial commentary, letters from readers, National Lipid Association (NLA) news and upcoming event information, as well as abstracts from the NLA annual scientific sessions and the scientific forums held by its chapters, when appropriate.